Co-managing laser cataract surgery

Article

Katherine M. Mastrota, OD, offers her view on one panelist’s presentation during the special session “Refractive/Cataract Surgery: The Future Revealed” at the 90th annual SECO International meeting in Atlanta.

Associate Optometric Editor Katherine M. Mastrota, OD, offers her view on one panelist’s presentation during the special session “Refractive/Cataract Surgery: The Future Revealed” at the 90th annual SECO International meeting in Atlanta:

Former Wills Eye Hospital surgeon Tyrie Jenkins, MD, spoke about her perspective on femtosecond laser cataract surgery, the implications of laser cataract surgery and OD cataract surgery co-management as part of a panel.

Dr. Jenkins, who is based in Honolulu, is a proponent of OD/MD cataract surgery co-management. She reviewed cataract surgery from couching to what may become the standard in cataract surgery today, laser-assisted cataract surgery. Laser-assisted cataract surgery has the potential to improve refractive outcomes and reduce cataract complications by creating a precise corneal incision and capsulorhexis as well as pre-treating the natural lens for removal with less phacoemulsification power.

The femtosecond photodisruptive laser produces microscopic bubbles that have the ability to divide material at a molecular level with no heat production. Interestingly, Dr. Jenkins notes that patient adoption of laser-assisted cataract surgery, currently an upcharge, is at 45% in her practice.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Melissa Tawa, OD, FAAO, provides insights to take glaucoma management from reactive to proactive in presentations given at CRU 2025 in Napa, California.
Rachelle Lin, OD, MS, FAAO, details her presentation on inherited retinal diseases at CRU 2025.
Setting the stage in LA: Neda Shamie, MD, on the 19th annual Controversies in Modern Eye Care meeting
Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Dr Paul Karpecki discusses atropine formulation from Sydnexis following NDA acceptance by FDA
© 2025 MJH Life Sciences

All rights reserved.